Heres a look at some recent weight loss results for semaglutide : In a phase 3 clinical trial of people with obesity, people taking the Wegovy injection (2.4 mg injectable semaglutide) lost an average of 14.9% of their body weight in 68 weeks (about a year and four months)
Two authors independently selected studies for inclusion and data extraction: only trials including patients with a diagnosis of peripheral neuropathy and involving at least 10 patients were considered for the purposes of this review
Cernak is an associate professor of medicinal chemistry at the University of Michigan
If you experience thoughts of suicide or self-harm, seek immediate help by calling 999, going to A&E, or contacting the Samaritans on 116 123
Medicines and Poisons Regulation Branch
Nolan JM, Meagher K, Kashani S, Beatty S